Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSSystematic literature reviews of submissions to EMA, FDA, and HTA bodies can help overcome operational and methodological hurdles and mitigate regulatory risk. While FDA and EMA online databases facilitate document retrieval, acquiring key documents from disparate HTA bodies can be complex.
Read this case study to learn how IQVIA's platforms and capabilities, including Natural Language Processing (NLP) and Instant Translation Platform enables a side-by-side comparison of regulatory and HTA feedback, leading to actionable insights and significant time-savings.
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.